Skip to content
MedsAcross

Medicine

Spironolactone 100 mg tablet

Available on requestPrescription onlyUS FDAGeneric name

Spironolactone 100 mg tablet is a generic prescription medicine for oral use, made by 27 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store below 77°F (25°C).

Key facts

Active ingredient (INN)
Spironolactone
Brand
Sold under the generic name
Strength
100 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 30 tablets and 128 more
Manufacturers
Zydus LifesciencesIndiaCamber PharmaceuticalsIndiaJubilant Cadista PharmaceuticalsIndiaSun Pharmaceutical IndustriesIndiaAccord HealthcareIndiaAurobindo PharmaIndiaAmneal PharmaceuticalsAmneal Pharmaceuticals of New York27 labelers on the register
Origin register
US FDA, United States
Storage
Store below 77°F (25°C).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C03DA01 Spironolactone
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
23 July 1986
Identifiers
RxCUI 198222, 198223, 313096DailyMed set ID db22e9e5-2d88-4712-a809-c00881edb447, c0efa529-2870-4260-b604-2f30e2cbb87b, 08738ad4-1607-4d55-af71-6790477353bd +37NDC 76420-927, 43063-835, 50090-6539 +37Application ANDA040750, ANDA203512, ANDA089424 +7

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 27 labelers. The register lists 131 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
100 tablet, film coated in 1 bottle59746-218-01Jubilant Cadista PharmacuticalsIndia4 April 2017
500 tablet, film coated in 1 bottle59746-218-05Jubilant Cadista PharmacuticalsIndia4 April 2017
100 tablet, film coated in 1 bottle59746-218-06Jubilant Cadista PharmacuticalsIndia4 April 2017
500 tablet, film coated in 1 bottle59746-218-09Jubilant Cadista PharmacuticalsIndia4 April 2017
100 tablet, film coated in 1 bottle68382-662-01Zydus LifesciencesIndia15 August 2018
500 tablet, film coated in 1 bottle68382-662-05Zydus LifesciencesIndia15 August 2018
30 tablet, film coated in 1 bottle68382-662-06Zydus LifesciencesIndia15 August 2018
1000 tablet, film coated in 1 bottle68382-662-10Zydus LifesciencesIndia15 August 2018
90 tablet, film coated in 1 bottle68382-662-16Zydus LifesciencesIndia15 August 2018
10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack68382-662-30Zydus LifesciencesIndia15 August 2018
1000 tablet, film coated in 1 bottle70771-1029-0Zydus LifesciencesIndia15 August 2018
100 tablet, film coated in 1 bottle70771-1029-1Zydus LifesciencesIndia15 August 2018
30 tablet, film coated in 1 bottle70771-1029-3Zydus LifesciencesIndia15 August 2018
10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack70771-1029-4Zydus LifesciencesIndia15 August 2018
500 tablet, film coated in 1 bottle70771-1029-5Zydus LifesciencesIndia15 August 2018
90 tablet, film coated in 1 bottle70771-1029-9Zydus LifesciencesIndia15 August 2018
100 tablet, film coated in 1 bottle16729-227-01Accord HealthcareIndia2 June 2017
500 tablet, film coated in 1 bottle16729-227-16Accord HealthcareIndia2 June 2017
100 tablet in 1 bottle59651-428-01Aurobindo PharmaIndia13 December 2019
500 tablet in 1 bottle59651-428-05Aurobindo PharmaIndia24 August 2023
100 tablet, film coated in 1 bottle31722-096-01Camber PharmaceuticalsIndia25 July 2025
500 tablet, film coated in 1 bottle31722-096-05Camber PharmaceuticalsIndia25 July 2025
1000 tablet, film coated in 1 bottle31722-096-10Camber PharmaceuticalsIndia25 July 2025
30 tablet, film coated in 1 bottle31722-096-30Camber PharmaceuticalsIndia25 July 2025
50 tablet, film coated in 1 bottle, plastic53489-329-02Sun Pharmaceutical IndustriesIndia23 July 1986
250 tablet, film coated in 1 bottle, plastic53489-329-03Sun Pharmaceutical IndustriesIndia23 July 1986
500 tablet, film coated in 1 bottle, plastic53489-329-05Sun Pharmaceutical IndustriesIndia23 July 1986
1000 tablet, film coated in 1 bottle, plastic53489-329-10Sun Pharmaceutical IndustriesIndia23 July 1986
30 tablet in 1 bottle65162-515-03Amneal Pharmaceuticals2 August 2010
60 tablet in 1 bottle65162-515-06Amneal Pharmaceuticals2 August 2010
90 tablet in 1 bottle65162-515-09Amneal Pharmaceuticals2 August 2010
100 tablet in 1 bottle65162-515-10Amneal Pharmaceuticals2 August 2010
1000 tablet in 1 bottle65162-515-11Amneal Pharmaceuticals2 August 2010
500 tablet in 1 bottle65162-515-50Amneal Pharmaceuticals2 August 2010
100 tablet in 1 blister pack65162-515-60Amneal Pharmaceuticals2 August 2010
100 tablet in 1 bottle53746-515-01Amneal Pharmaceuticals of New York2 August 2010
500 tablet in 1 bottle53746-515-05Amneal Pharmaceuticals of New York2 August 2010
1000 tablet in 1 bottle53746-515-10Amneal Pharmaceuticals of New York2 August 2010
30 tablet in 1 bottle53746-515-30Amneal Pharmaceuticals of New York2 August 2010
60 tablet in 1 bottle53746-515-60Amneal Pharmaceuticals of New York2 August 2010

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 21 January 1960Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Spironolactone 100 mg tablet.

Compare 1

Other strengths and forms of Spironolactone

Clinical summary

Spironolactone is an aldosterone antagonist indicated for the treatment of NYHA Class III–IV heart failure and reduced ejection fraction to increase survival, manage edema, and to reduce the need for hospitalization for heart failure. MedsAcross supplies Spironolactone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Spironolactone

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Spironolactone 100 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.